| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 8.42e-07 | 4 | 8 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.11e-06 | 6 | 8 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.14e-05 | 18 | 8 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 6.49e-05 | 31 | 8 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.37e-05 | 33 | 8 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.13e-03 | 129 | 8 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.33e-03 | 140 | 8 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.54e-03 | 151 | 8 | 2 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.50e-03 | 193 | 8 | 2 | GO:0015276 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.56e-03 | 749 | 8 | 3 | GO:0005509 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.61e-03 | 197 | 8 | 2 | GO:0022834 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.53e-03 | 230 | 8 | 2 | GO:0005516 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.31e-03 | 334 | 8 | 2 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.69e-03 | 343 | 8 | 2 | GO:0005261 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 9.21e-03 | 1180 | 8 | 3 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 1.18e-02 | 1289 | 8 | 3 | GO:0005215 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.35e-02 | 459 | 8 | 2 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.38e-02 | 465 | 8 | 2 | GO:0046873 | |
| GeneOntologyMolecularFunction | channel activity | 1.74e-02 | 525 | 8 | 2 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.75e-02 | 526 | 8 | 2 | GO:0022803 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.43e-02 | 627 | 8 | 2 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.71e-02 | 664 | 8 | 2 | GO:0008324 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 9.29e-06 | 11 | 9 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.54e-05 | 14 | 9 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | response to caffeine | 3.54e-05 | 21 | 9 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.12e-04 | 37 | 9 | 2 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.24e-04 | 39 | 9 | 2 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 1.31e-04 | 40 | 9 | 2 | GO:0071312 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.59e-04 | 44 | 9 | 2 | GO:0070296 | |
| GeneOntologyBiologicalProcess | response to hypoxia | 3.71e-04 | 348 | 9 | 3 | GO:0001666 | |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | 4.23e-04 | 364 | 9 | 3 | GO:0036293 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 5.79e-04 | 84 | 9 | 2 | GO:0051480 | |
| GeneOntologyBiologicalProcess | response to oxygen levels | 6.88e-04 | 430 | 9 | 3 | GO:0070482 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 1.28e-03 | 125 | 9 | 2 | GO:0043279 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 1.73e-03 | 146 | 9 | 2 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 1.76e-03 | 147 | 9 | 2 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 1.81e-03 | 149 | 9 | 2 | GO:0051282 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 1.82e-03 | 1361 | 9 | 4 | GO:0009628 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.90e-03 | 153 | 9 | 2 | GO:0051208 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 2.10e-03 | 161 | 9 | 2 | GO:0051592 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.23e-03 | 166 | 9 | 2 | GO:0014074 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 3.28e-03 | 202 | 9 | 2 | GO:0006937 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 3.44e-03 | 752 | 9 | 3 | GO:1901699 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 3.78e-03 | 217 | 9 | 2 | GO:0006941 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 3.78e-03 | 217 | 9 | 2 | GO:0097553 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 5.33e-03 | 259 | 9 | 2 | GO:0051651 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 5.62e-03 | 266 | 9 | 2 | GO:0019722 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 7.89e-03 | 317 | 9 | 2 | GO:0090257 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 8.09e-03 | 321 | 9 | 2 | GO:0003007 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.00e-02 | 359 | 9 | 2 | GO:0006874 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 7.40e-06 | 10 | 9 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.62e-04 | 45 | 9 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.69e-04 | 46 | 9 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 2.51e-04 | 56 | 9 | 2 | GO:0031234 | |
| GeneOntologyCellularComponent | calcium channel complex | 4.26e-04 | 73 | 9 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 6.19e-04 | 88 | 9 | 2 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.04e-03 | 114 | 9 | 2 | GO:0016528 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.49e-03 | 137 | 9 | 2 | GO:0019897 | |
| GeneOntologyCellularComponent | Z disc | 1.80e-03 | 151 | 9 | 2 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 2.18e-03 | 166 | 9 | 2 | GO:0031674 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.69e-03 | 185 | 9 | 2 | GO:0009898 | |
| GeneOntologyCellularComponent | sarcolemma | 2.84e-03 | 190 | 9 | 2 | GO:0042383 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 4.12e-03 | 230 | 9 | 2 | GO:0098562 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 4.12e-03 | 230 | 9 | 2 | GO:0019898 | |
| GeneOntologyCellularComponent | cation channel complex | 4.30e-03 | 235 | 9 | 2 | GO:0034703 | |
| GeneOntologyCellularComponent | sarcomere | 4.81e-03 | 249 | 9 | 2 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 5.76e-03 | 273 | 9 | 2 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.47e-03 | 290 | 9 | 2 | GO:0043292 | |
| GeneOntologyCellularComponent | cell cortex | 1.04e-02 | 371 | 9 | 2 | GO:0005938 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.08e-02 | 378 | 9 | 2 | GO:0034702 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 1.50e-02 | 1293 | 9 | 3 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.52e-02 | 1299 | 9 | 3 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 1.61e-02 | 1327 | 9 | 3 | GO:0042175 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.00e-02 | 523 | 9 | 2 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 2.20e-02 | 550 | 9 | 2 | GO:1990351 | |
| HumanPheno | Premature ventricular contraction | 3.13e-05 | 29 | 2 | 2 | HP:0006682 | |
| HumanPheno | Ventricular tachycardia | 1.81e-04 | 69 | 2 | 2 | HP:0004756 | |
| HumanPheno | Abnormal electrophysiology of sinoatrial node origin | 2.50e-04 | 81 | 2 | 2 | HP:0011702 | |
| HumanPheno | Supraventricular tachycardia | 5.50e-04 | 120 | 2 | 2 | HP:0004755 | |
| HumanPheno | Supraventricular arrhythmia | 6.87e-04 | 134 | 2 | 2 | HP:0005115 | |
| HumanPheno | Vertigo | 8.16e-04 | 146 | 2 | 2 | HP:0002321 | |
| HumanPheno | Tachycardia | 1.37e-03 | 189 | 2 | 2 | HP:0001649 | |
| HumanPheno | Abnormal vestibular function | 1.72e-03 | 212 | 2 | 2 | HP:0001751 | |
| HumanPheno | Ventricular arrhythmia | 2.38e-03 | 249 | 2 | 2 | HP:0004308 | |
| HumanPheno | Congestive heart failure | 2.97e-03 | 278 | 2 | 2 | HP:0001635 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 7.21e-05 | 23 | 8 | 2 | MP:0004088 | |
| MousePheno | abnormal muscle fiber mitochondrial morphology | 1.50e-04 | 33 | 8 | 2 | MP:0014342 | |
| Domain | RR_TM4-6 | 6.19e-07 | 3 | 9 | 2 | PF06459 | |
| Domain | Ryanrecept_TM4-6 | 6.19e-07 | 3 | 9 | 2 | IPR009460 | |
| Domain | RyR | 6.19e-07 | 3 | 9 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 6.19e-07 | 3 | 9 | 2 | IPR003032 | |
| Domain | Ryan_recept | 6.19e-07 | 3 | 9 | 2 | IPR013333 | |
| Domain | RIH_assoc | 3.09e-06 | 6 | 9 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 3.09e-06 | 6 | 9 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.09e-06 | 6 | 9 | 2 | PF08709 | |
| Domain | RYDR_ITPR | 3.09e-06 | 6 | 9 | 2 | PF01365 | |
| Domain | RIH_dom | 3.09e-06 | 6 | 9 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.09e-06 | 6 | 9 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.09e-06 | 6 | 9 | 2 | IPR015925 | |
| Domain | - | 3.09e-06 | 6 | 9 | 2 | 1.25.10.30 | |
| Domain | MIR | 9.27e-06 | 10 | 9 | 2 | PS50919 | |
| Domain | MIR | 9.27e-06 | 10 | 9 | 2 | PF02815 | |
| Domain | MIR | 9.27e-06 | 10 | 9 | 2 | SM00472 | |
| Domain | MIR_motif | 9.27e-06 | 10 | 9 | 2 | IPR016093 | |
| Domain | EF-hand_8 | 1.15e-04 | 34 | 9 | 2 | PF13833 | |
| Domain | EF_hand_dom | 1.50e-04 | 232 | 9 | 3 | IPR002048 | |
| Domain | - | 2.13e-04 | 261 | 9 | 3 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 2.82e-04 | 287 | 9 | 3 | IPR011992 | |
| Domain | SPRY | 7.56e-04 | 87 | 9 | 2 | SM00449 | |
| Domain | SPRY | 8.82e-04 | 94 | 9 | 2 | PF00622 | |
| Domain | SPRY_dom | 8.82e-04 | 94 | 9 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 9.00e-04 | 95 | 9 | 2 | IPR001870 | |
| Domain | B302_SPRY | 9.00e-04 | 95 | 9 | 2 | PS50188 | |
| Domain | Ion_trans_dom | 1.29e-03 | 114 | 9 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.29e-03 | 114 | 9 | 2 | PF00520 | |
| Domain | EF-hand_1 | 2.28e-03 | 152 | 9 | 2 | PF00036 | |
| Domain | EFh | 2.46e-03 | 158 | 9 | 2 | SM00054 | |
| Domain | ConA-like_dom | 4.67e-03 | 219 | 9 | 2 | IPR013320 | |
| Domain | EF_HAND_2 | 5.18e-03 | 231 | 9 | 2 | PS50222 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 8.29e-06 | 11 | 6 | 2 | M47958 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.18e-05 | 13 | 6 | 2 | M39589 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.57e-05 | 19 | 6 | 2 | M47760 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 1.55e-04 | 46 | 6 | 2 | M48105 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.14e-04 | 54 | 6 | 2 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.14e-04 | 54 | 6 | 2 | MM15202 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 7.19e-04 | 99 | 6 | 2 | MM14910 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 7.78e-04 | 103 | 6 | 2 | MM15196 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.24e-04 | 106 | 6 | 2 | M27200 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.24e-03 | 130 | 6 | 2 | M27454 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.58e-03 | 147 | 6 | 2 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.66e-03 | 151 | 6 | 2 | M39329 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.73e-03 | 154 | 6 | 2 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.77e-03 | 156 | 6 | 2 | M39475 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.98e-03 | 165 | 6 | 2 | MM15026 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.25e-03 | 176 | 6 | 2 | MM15718 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.30e-03 | 178 | 6 | 2 | M2890 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.43e-03 | 183 | 6 | 2 | M997 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.98e-03 | 203 | 6 | 2 | M5485 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 5.95e-08 | 2 | 9 | 2 | 26009179 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 5.95e-08 | 2 | 9 | 2 | 11673493 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 11673462 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 5.95e-08 | 2 | 9 | 2 | 18618700 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 17259277 | ||
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 30542613 | ||
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 32899693 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 5.95e-08 | 2 | 9 | 2 | 25370123 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 5.95e-08 | 2 | 9 | 2 | 15033925 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 5.95e-08 | 2 | 9 | 2 | 14722100 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.79e-07 | 3 | 9 | 2 | 7621815 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.79e-07 | 3 | 9 | 2 | 9204703 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 18643873 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 11159936 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.79e-07 | 3 | 9 | 2 | 10788707 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 23278119 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 7876312 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 18434746 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 9242641 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 18403125 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.79e-07 | 3 | 9 | 2 | 10473538 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 21881589 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 1.79e-07 | 3 | 9 | 2 | 9986730 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 24123915 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 7959768 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.79e-07 | 3 | 9 | 2 | 12213830 | |
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.79e-07 | 3 | 9 | 2 | 4600883 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 22948152 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 1.79e-07 | 3 | 9 | 2 | 23454728 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 7635066 | ||
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 9607712 | ||
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 9384575 | ||
| Pubmed | Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release. | 3.57e-07 | 4 | 9 | 2 | 23992453 | |
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 18206662 | ||
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 23482488 | ||
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 19120137 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.57e-07 | 4 | 9 | 2 | 23413940 | |
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 22504960 | ||
| Pubmed | FKBP binding characteristics of cardiac microsomes from diverse vertebrates. | 3.57e-07 | 4 | 9 | 2 | 11237759 | |
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 27226555 | ||
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 5.95e-07 | 5 | 9 | 2 | 9124414 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 5.95e-07 | 5 | 9 | 2 | 19011160 | |
| Pubmed | 5.95e-07 | 5 | 9 | 2 | 23918386 | ||
| Pubmed | Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. | 5.95e-07 | 5 | 9 | 2 | 22939628 | |
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 19549818 | ||
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 19009018 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 8.92e-07 | 6 | 9 | 2 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 8.92e-07 | 6 | 9 | 2 | 16844763 | |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 8.92e-07 | 6 | 9 | 2 | 26025922 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 8.92e-07 | 6 | 9 | 2 | 14592808 | |
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 23463619 | ||
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 20519450 | ||
| Pubmed | 1.25e-06 | 7 | 9 | 2 | 20962236 | ||
| Pubmed | 1.25e-06 | 7 | 9 | 2 | 11860456 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.67e-06 | 8 | 9 | 2 | 19033399 | |
| Pubmed | 1.67e-06 | 8 | 9 | 2 | 11784029 | ||
| Pubmed | 2.68e-06 | 10 | 9 | 2 | 18434328 | ||
| Pubmed | 3.92e-06 | 12 | 9 | 2 | 19095005 | ||
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 5.41e-06 | 14 | 9 | 2 | 28724790 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.16e-05 | 38 | 9 | 2 | 30786075 | |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 9.43e-05 | 57 | 9 | 2 | 23788249 | |
| Interaction | AKAP6 interactions | 1.87e-05 | 17 | 8 | 2 | int:AKAP6 | |
| Interaction | RYR1 interactions | 1.24e-04 | 43 | 8 | 2 | int:RYR1 | |
| Interaction | RYR2 interactions | 2.25e-04 | 58 | 8 | 2 | int:RYR2 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.75e-07 | 3 | 6 | 2 | 287 | |
| GeneFamily | EF-hand domain containing | 2.12e-03 | 219 | 6 | 2 | 863 | |
| Coexpression | PIEPOLI_LGI1_TARGETS_UP | 1.42e-05 | 17 | 9 | 2 | M15008 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.00e-05 | 165 | 9 | 3 | M9105 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HMGL | 2.68e-05 | 577 | 9 | 4 | M39051 | |
| Coexpression | GSE13306_TREG_VS_TCONV_SPLEEN_DN | 3.50e-05 | 199 | 9 | 3 | M3225 | |
| Coexpression | TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL | 8.67e-05 | 270 | 9 | 3 | M41699 | |
| Coexpression | HU_FETAL_RETINA_MICROGLIA | 2.42e-04 | 382 | 9 | 3 | M39266 | |
| Coexpression | HAY_BONE_MARROW_NEUTROPHIL | 3.91e-04 | 450 | 9 | 3 | M39203 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP | 7.48e-04 | 562 | 9 | 3 | M41008 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_MYELOID_CELLS | 1.08e-03 | 146 | 9 | 2 | M40285 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.38e-03 | 165 | 9 | 2 | M9109 | |
| Coexpression | GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 1.38e-03 | 165 | 9 | 2 | M337 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 1.39e-03 | 166 | 9 | 2 | M12595 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.44e-03 | 169 | 9 | 2 | M9102 | |
| Coexpression | DESCARTES_FETAL_THYMUS_ANTIGEN_PRESENTING_CELLS | 1.51e-03 | 173 | 9 | 2 | M40314 | |
| Coexpression | GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN | 1.55e-03 | 175 | 9 | 2 | M6720 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 1.76e-03 | 187 | 9 | 2 | MM1034 | |
| Coexpression | E2F3_UP.V1_UP | 1.82e-03 | 190 | 9 | 2 | M2706 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 1.88e-03 | 193 | 9 | 2 | M39321 | |
| Coexpression | GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP | 1.97e-03 | 198 | 9 | 2 | M9960 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN | 1.99e-03 | 199 | 9 | 2 | M7341 | |
| Coexpression | GSE17721_4H_VS_24H_POLYIC_BMDC_UP | 1.99e-03 | 199 | 9 | 2 | M4098 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP | 1.99e-03 | 199 | 9 | 2 | M6260 | |
| Coexpression | GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN | 1.99e-03 | 199 | 9 | 2 | M6351 | |
| Coexpression | GSE17721_CTRL_VS_LPS_6H_BMDC_DN | 1.99e-03 | 199 | 9 | 2 | M3692 | |
| Coexpression | GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP | 2.01e-03 | 200 | 9 | 2 | M9023 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN | 2.01e-03 | 200 | 9 | 2 | M4616 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 2.01e-03 | 200 | 9 | 2 | M5282 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M5045 | |
| Coexpression | GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP | 2.01e-03 | 200 | 9 | 2 | M9699 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 2.01e-03 | 200 | 9 | 2 | M6655 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN | 2.01e-03 | 200 | 9 | 2 | M7744 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN | 2.01e-03 | 200 | 9 | 2 | M4496 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN | 2.01e-03 | 200 | 9 | 2 | M4480 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP | 2.01e-03 | 200 | 9 | 2 | M7322 | |
| Coexpression | GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN | 2.01e-03 | 200 | 9 | 2 | M4878 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN | 2.01e-03 | 200 | 9 | 2 | M6639 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3823 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN | 2.01e-03 | 200 | 9 | 2 | M9383 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP | 2.01e-03 | 200 | 9 | 2 | M7333 | |
| Coexpression | AIZARANI_LIVER_C2_KUPFFER_CELLS_1 | 2.01e-03 | 200 | 9 | 2 | M39106 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 2.01e-03 | 200 | 9 | 2 | M5956 | |
| Coexpression | GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN | 2.01e-03 | 200 | 9 | 2 | M6580 | |
| Coexpression | GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M8522 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN | 2.01e-03 | 200 | 9 | 2 | M4506 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_DC_DN | 2.01e-03 | 200 | 9 | 2 | M4503 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TCONV_DN | 2.01e-03 | 200 | 9 | 2 | M3235 | |
| Coexpression | GSE13306_TREG_VS_TCONV_DN | 2.01e-03 | 200 | 9 | 2 | M3230 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M4327 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-06 | 164 | 9 | 3 | 3281f2452cc6b11f3e030a3942002b9457dde6fe | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-06 | 164 | 9 | 3 | 939d4e3911fce185b986639c815de0a0389f6cfd | |
| ToppCell | droplet-Liver-LIVER|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 167 | 9 | 3 | 90125bfdc34b0f9a471cefe6e8a637d5e5e00790 | |
| ToppCell | droplet-Liver-LIVER-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 167 | 9 | 3 | 4bbc59cc50a68b957125fb11a3b308fe1d542ce9 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 167 | 9 | 3 | a038c522e4783cb62802f613d00bd5f3e3797199 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.37e-06 | 182 | 9 | 3 | d57d18732aa6fb7b2d430601568f9ba525ac6e3c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.37e-06 | 182 | 9 | 3 | 9a68d3bd1cc9139de9e9e711c249d47ade826bb1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.37e-06 | 182 | 9 | 3 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-06 | 188 | 9 | 3 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.41e-06 | 193 | 9 | 3 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.51e-06 | 194 | 9 | 3 | 7c7091de47359760003e910cfbe63db5c99410d6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-06 | 194 | 9 | 3 | 6810586080cc893e3270b9c8bee2d95ed78e2893 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-06 | 194 | 9 | 3 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.61e-06 | 195 | 9 | 3 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.81e-06 | 197 | 9 | 3 | 94e2cc7ec531e58b8ed7e5601fdf8c4bbc3582c8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.81e-06 | 197 | 9 | 3 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.81e-06 | 197 | 9 | 3 | ffaf2d7b6aa82008bd64a691b48113626343872c | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.92e-06 | 198 | 9 | 3 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.92e-06 | 198 | 9 | 3 | 1d1c80569f1e307285ba0ebaf5c72e0b5b538864 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.92e-06 | 198 | 9 | 3 | f37578f156e8aed2ce30cfa837ae04dd18de05d0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.92e-06 | 198 | 9 | 3 | c79c1738560d78b63dbed5f2f9621dbc1c2363cb | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.92e-06 | 198 | 9 | 3 | 189346c5eb715f3be427bec3b8e067ababb5b475 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 199 | 9 | 3 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.02e-06 | 199 | 9 | 3 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 199 | 9 | 3 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.02e-06 | 199 | 9 | 3 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-06 | 200 | 9 | 3 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 7.13e-06 | 200 | 9 | 3 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-06 | 200 | 9 | 3 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-06 | 200 | 9 | 3 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | mLN-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 1.74e-04 | 100 | 9 | 2 | c560326f6ae5338aecdf11ef8adf04bc8769745c | |
| ToppCell | COVID-19-Heart-Fib_+_CM|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-04 | 104 | 9 | 2 | 0b60a56a46f1fe3f8224ec6399d009a34a117a21 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-04 | 105 | 9 | 2 | 8f31edf4183587f5b53941475453c5aa49f10bbd | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 2.68e-04 | 124 | 9 | 2 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | COVID-19-APC-like-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 2.77e-04 | 126 | 9 | 2 | 9f94291b1db020cc0ebf9c8de4e01bd883295672 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.81e-04 | 127 | 9 | 2 | 5e4d110cc6e68cd8fc7a4771a65e6f8cd83e7721 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-2|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.03e-04 | 132 | 9 | 2 | a8e7e7f38af095d63e221bcc06a1e5147bb6e467 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.13e-04 | 134 | 9 | 2 | 3b67c02b430b6d58467f36e606c478d3eea0063f | |
| ToppCell | P03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.46e-04 | 141 | 9 | 2 | 4a856521520ea73291f4730fe94c5de88c2b6f0c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_dendritic_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.86e-04 | 149 | 9 | 2 | 71d72a6e7b128ee96161e08f6a0d77be925e73a1 | |
| ToppCell | Dendritic_Cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.12e-04 | 154 | 9 | 2 | 65013f696da623d37f1e3447a294dfb3c31ae93b | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.18e-04 | 155 | 9 | 2 | b5d5c38b269e9318970fcce564df1c8ed7a7ccc6 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.40e-04 | 159 | 9 | 2 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.40e-04 | 159 | 9 | 2 | ebd840ac2b07e62086ee7b5bb01c21804a0fdc7b | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-04 | 160 | 9 | 2 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-04 | 160 | 9 | 2 | 709ce00699ca05346287868ea55a1affae0859a8 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | 5c28121916a12dbc22ef2421040bdc9148a40b78 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-04 | 160 | 9 | 2 | 229841be7b984a00a301cd5d88c11226a90d8a88 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-04 | 160 | 9 | 2 | 99c9ae2041445539fada842e1af01368669bfca0 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | b7093678987575f2f99d648821d31b4a37075aca | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.45e-04 | 160 | 9 | 2 | 9caab1bb63c7e66c44783852ee75b16bb40fa594 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-04 | 161 | 9 | 2 | 3db97af49520dc8cbafb4454d8afd9d588160e89 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-04 | 161 | 9 | 2 | f1d258c81bcf0f3c52bd20aa58faa9a5fd888168 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.51e-04 | 161 | 9 | 2 | 4362fe0c151f49eae7372b9673bac64d980a8389 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-04 | 161 | 9 | 2 | 787f91f906756ef570c0d02936c3cdfafb3f7454 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 4.62e-04 | 163 | 9 | 2 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-04 | 163 | 9 | 2 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-04 | 164 | 9 | 2 | e19fc6ba049336ab989a3a968bdbefd567971d73 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 4.68e-04 | 164 | 9 | 2 | 334f376350c9cf92611d0f75b2e18a102f4c116a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.68e-04 | 164 | 9 | 2 | 7077683afee91828ad2b95e0f81c2b27aae0f831 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-04 | 164 | 9 | 2 | d6526551d0b183c3ef027ba3dbfddeac03fd93bb | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.68e-04 | 164 | 9 | 2 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.68e-04 | 164 | 9 | 2 | 10741c7706a37b24aa08a300b27d60d6b8600167 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 165 | 9 | 2 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.73e-04 | 165 | 9 | 2 | e460e03992781073cd836a655f15dda3157cea55 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 166 | 9 | 2 | 03a47b8687f54955e84df1edcb230db332c4ca8f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 166 | 9 | 2 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.79e-04 | 166 | 9 | 2 | 6210a136efb99d70c2026b6454363f1bd2723558 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.79e-04 | 166 | 9 | 2 | 9f14e3ef19d5903278c040be1c477501237173fa | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 167 | 9 | 2 | c2952d8ba763374c5678b92825c8956fc3e3ecd2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.90e-04 | 168 | 9 | 2 | d6078e3a79d315d6090906e171a7d67a9206b2c7 | |
| ToppCell | Monocytes-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.90e-04 | 168 | 9 | 2 | 9ea3c682ce4e98f1a3303f99b4c63c2cf8863abc | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.90e-04 | 168 | 9 | 2 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.96e-04 | 169 | 9 | 2 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.96e-04 | 169 | 9 | 2 | 9c9bb1b32fc6e22359424a262178906c3954415d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-04 | 169 | 9 | 2 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.96e-04 | 169 | 9 | 2 | e3100eb587005e160bd0b7990fa57ec49765133d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-04 | 170 | 9 | 2 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-04 | 170 | 9 | 2 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-04 | 170 | 9 | 2 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-04 | 170 | 9 | 2 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.02e-04 | 170 | 9 | 2 | 1c3c03821c90d41de92fef3278f71093a7fd709c | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-04 | 170 | 9 | 2 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-04 | 170 | 9 | 2 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-04 | 170 | 9 | 2 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 171 | 9 | 2 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 171 | 9 | 2 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-04 | 171 | 9 | 2 | 38a05b5ec8ef8f09a2399994c6b4b9a707918ec1 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 171 | 9 | 2 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 171 | 9 | 2 | 8bed33f61f7d12a1ac4fba33f730d839f5ee7bef | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 171 | 9 | 2 | 0385d5834ae16bbb0c6a68893fec60e4dd1e478d | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 171 | 9 | 2 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 171 | 9 | 2 | a3e3fe0cbab21abb178c482f5951e576529f7e30 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-04 | 172 | 9 | 2 | ac20766d1fd43eab8c3ff5e7418a6b38bebf0bd5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-04 | 172 | 9 | 2 | 3fd1bc4a8ced0bf9e26ca4ce6d83b5b97bbc2556 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | a5344760b10ecdc0101f78b93b8fc0f8107068c5 | |
| ToppCell | droplet-Spleen-nan-21m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | 3dc02709c2a6be2155576e5c34e1b0b3ae19b061 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-04 | 173 | 9 | 2 | d17e50dc400098374af626803dec1241ec566769 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.20e-04 | 173 | 9 | 2 | b335ca2a247156eba821943b2b9fc9922230b409 | |
| Computational | Neighborhood of FOS | 2.95e-04 | 41 | 7 | 2 | GNF2_FOS | |
| Computational | Neighborhood of CD33 | 4.75e-04 | 52 | 7 | 2 | GNF2_CD33 | |
| Computational | Neighborhood of PECAM1 | 5.51e-04 | 56 | 7 | 2 | GNF2_PECAM1 | |
| Computational | Ion channels. | 8.60e-04 | 70 | 7 | 2 | MODULE_316 | |
| Computational | Neighborhood of CARD15 | 8.60e-04 | 70 | 7 | 2 | GNF2_CARD15 | |
| Computational | Neighborhood of CASP1 | 2.15e-03 | 111 | 7 | 2 | GNF2_CASP1 | |
| Drug | 2-hydroxyheptanoic acid | 4.17e-07 | 3 | 9 | 2 | CID002750949 | |
| Drug | 2-hydroxycarbazole | 4.17e-07 | 3 | 9 | 2 | CID000093551 | |
| Drug | aminodantrolene | 4.17e-07 | 3 | 9 | 2 | CID009570289 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 4.17e-07 | 3 | 9 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 4.17e-07 | 3 | 9 | 2 | CID000127713 | |
| Drug | cis-diammineplatinum(II | 4.17e-07 | 3 | 9 | 2 | CID000159790 | |
| Drug | AC1L1U7A | 8.33e-07 | 4 | 9 | 2 | CID000035682 | |
| Drug | PCB74 | 8.33e-07 | 4 | 9 | 2 | CID000036218 | |
| Drug | SC 38249 | 8.33e-07 | 4 | 9 | 2 | CID000134834 | |
| Drug | 148504-47-6 | 8.33e-07 | 4 | 9 | 2 | CID006444275 | |
| Drug | A 68930 | 1.39e-06 | 5 | 9 | 2 | ctd:C065380 | |
| Drug | NSC114784 | 2.08e-06 | 6 | 9 | 2 | CID000419425 | |
| Drug | MBED | 2.08e-06 | 6 | 9 | 2 | CID000129958 | |
| Drug | AC1O528X | 2.08e-06 | 6 | 9 | 2 | CID006475857 | |
| Drug | chloro-m-cresol | 2.08e-06 | 6 | 9 | 2 | CID000012008 | |
| Drug | Azumoleno | 2.91e-06 | 7 | 9 | 2 | CID000056259 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.91e-06 | 7 | 9 | 2 | CID009547999 | |
| Drug | Br2BAPTA | 2.91e-06 | 7 | 9 | 2 | CID003081001 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 3.33e-06 | 79 | 9 | 3 | CID005287890 | |
| Drug | manidipine | 5.80e-06 | 95 | 9 | 3 | CID000004008 | |
| Drug | PCB 95 | 6.24e-06 | 10 | 9 | 2 | CID000038012 | |
| Drug | PCB 66 | 7.63e-06 | 11 | 9 | 2 | CID000036185 | |
| Drug | R 478 | 7.63e-06 | 11 | 9 | 2 | CID000084223 | |
| Drug | 2,3,6,2',3',6'-hexachlorobiphenyl | 7.63e-06 | 11 | 9 | 2 | ctd:C010498 | |
| Drug | 8-amino-cADPR | 7.63e-06 | 11 | 9 | 2 | CID003081323 | |
| Drug | tectoridin | 7.63e-06 | 11 | 9 | 2 | CID005281810 | |
| Drug | Ryanodine | 9.15e-06 | 12 | 9 | 2 | ctd:D012433 | |
| Drug | AC1L1KF5 | 9.78e-06 | 113 | 9 | 3 | CID000005470 | |
| Drug | FPL 64176 | 1.45e-05 | 15 | 9 | 2 | CID000003423 | |
| Drug | Gvapspat amide | 1.45e-05 | 15 | 9 | 2 | CID000125015 | |
| Drug | kazinol B | 1.88e-05 | 17 | 9 | 2 | CID000480869 | |
| Drug | methylcoumarin | 2.12e-05 | 18 | 9 | 2 | CID000007092 | |
| Drug | AC1L380G | 2.37e-05 | 19 | 9 | 2 | CID000084698 | |
| Drug | AC1MW7VF | 2.37e-05 | 19 | 9 | 2 | CID000414699 | |
| Drug | SK&F 82958 | 2.37e-05 | 19 | 9 | 2 | ctd:C071262 | |
| Drug | Baclofen | 2.63e-05 | 20 | 9 | 2 | ctd:D001418 | |
| Drug | 2,2',3,5',6-pentachlorobiphenyl | 2.63e-05 | 20 | 9 | 2 | ctd:C032904 | |
| Drug | indo-1/AM | 2.91e-05 | 21 | 9 | 2 | CID000123918 | |
| Drug | tectorigenin | 2.91e-05 | 21 | 9 | 2 | CID005281811 | |
| Drug | T0702 | 4.15e-05 | 25 | 9 | 2 | CID000005908 | |
| Drug | dihydropyridine | 4.85e-05 | 193 | 9 | 3 | CID000104822 | |
| Drug | Bicuculline | 5.61e-05 | 29 | 9 | 2 | ctd:D001640 | |
| Drug | 2,4-xylidinothiazoline | 6.01e-05 | 30 | 9 | 2 | CID000099296 | |
| Drug | LOPAC | 6.01e-05 | 30 | 9 | 2 | CID000062696 | |
| Drug | M-HN | 6.42e-05 | 31 | 9 | 2 | CID000015450 | |
| Drug | M3/M4 | 6.85e-05 | 32 | 9 | 2 | CID000486507 | |
| Drug | IHC-64 | 7.29e-05 | 33 | 9 | 2 | CID000162753 | |
| Drug | CNS 1145 | 7.29e-05 | 33 | 9 | 2 | CID000190902 | |
| Drug | mag-fura-2 | 9.18e-05 | 37 | 9 | 2 | CID000123839 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 9.18e-05 | 37 | 9 | 2 | CID000009643 | |
| Drug | 4-chloro-m-cresol | 9.18e-05 | 37 | 9 | 2 | CID000001732 | |
| Drug | AC1L98DX | 9.69e-05 | 38 | 9 | 2 | CID000439957 | |
| Drug | NAADP | 1.02e-04 | 39 | 9 | 2 | CID000123952 | |
| Drug | dipyrone | 1.08e-04 | 40 | 9 | 2 | CID000003110 | |
| Drug | Dantrolene | 1.13e-04 | 41 | 9 | 2 | ctd:D003620 | |
| Drug | escina | 1.30e-04 | 44 | 9 | 2 | CID006433489 | |
| Drug | 4,4'-dithiodipyridine | 1.36e-04 | 45 | 9 | 2 | CID000075846 | |
| Drug | U46619 | 1.54e-04 | 285 | 9 | 3 | CID000005618 | |
| Drug | ts M | 1.55e-04 | 48 | 9 | 2 | CID000428025 | |
| Drug | Trp-Trp | 1.62e-04 | 49 | 9 | 2 | CID000088656 | |
| Drug | AC1L9KQO | 1.62e-04 | 49 | 9 | 2 | CID000447335 | |
| Drug | etridiazole | 1.68e-04 | 50 | 9 | 2 | CID000017432 | |
| Drug | Cinildipine | 2.12e-04 | 56 | 9 | 2 | CID000002752 | |
| Drug | BAPNA | 2.19e-04 | 57 | 9 | 2 | CID000013494 | |
| Drug | cysteinylglycine | 2.19e-04 | 57 | 9 | 2 | CID000065270 | |
| Drug | N-benzoyl-L-arginine | 2.27e-04 | 58 | 9 | 2 | CID000097369 | |
| Drug | Coversyl | 2.43e-04 | 60 | 9 | 2 | CID000060184 | |
| Drug | nilvadipine | 2.43e-04 | 60 | 9 | 2 | CID000004494 | |
| Drug | IAA-94 | 2.51e-04 | 61 | 9 | 2 | CID000003667 | |
| Drug | Tacrolimus | 2.57e-04 | 339 | 9 | 3 | ctd:D016559 | |
| Drug | lercanidipine | 2.68e-04 | 63 | 9 | 2 | CID000065866 | |
| Drug | succinylcholine | 2.76e-04 | 64 | 9 | 2 | CID000005314 | |
| Drug | fura 2 | 2.85e-04 | 65 | 9 | 2 | CID000057054 | |
| Drug | gallopamil | 3.03e-04 | 67 | 9 | 2 | CID000001234 | |
| Drug | strontium | 3.12e-04 | 68 | 9 | 2 | CID000104798 | |
| Drug | tBuBHQ | 3.21e-04 | 69 | 9 | 2 | CID000002374 | |
| Drug | AC1L2AC7 | 3.21e-04 | 69 | 9 | 2 | CID000068733 | |
| Drug | 2-aminopyridine | 3.31e-04 | 70 | 9 | 2 | CID000010439 | |
| Drug | Digocin | 3.31e-04 | 70 | 9 | 2 | CID000003062 | |
| Drug | flecainide | 3.40e-04 | 71 | 9 | 2 | CID000003355 | |
| Drug | AC1L1D8L | 3.40e-04 | 71 | 9 | 2 | CID000002241 | |
| Drug | peroxynitrite | 3.40e-04 | 373 | 9 | 3 | CID000104806 | |
| Drug | CAS 298-57-7 | 3.60e-04 | 73 | 9 | 2 | CID000002761 | |
| Drug | valproate | 3.62e-04 | 381 | 9 | 3 | CID000003121 | |
| Drug | ethosuximide | 3.70e-04 | 74 | 9 | 2 | CID000003291 | |
| Drug | Benazepril-d5 | 4.00e-04 | 77 | 9 | 2 | CID000002311 | |
| Drug | aldosterone | 4.09e-04 | 397 | 9 | 3 | CID000005839 | |
| Drug | nisoldipine | 4.11e-04 | 78 | 9 | 2 | CID000004499 | |
| Drug | Fura-2AM | 4.21e-04 | 79 | 9 | 2 | CID000105091 | |
| Drug | cADPR | 4.54e-04 | 82 | 9 | 2 | CID000123847 | |
| Drug | XeC compound | 4.76e-04 | 84 | 9 | 2 | CID000005701 | |
| Drug | europium | 5.11e-04 | 87 | 9 | 2 | CID000023981 | |
| Drug | tetracaine | 5.22e-04 | 88 | 9 | 2 | CID000005411 | |
| Drug | olmesartan | 5.59e-04 | 91 | 9 | 2 | CID000158781 | |
| Drug | adenosine diphosphoribose | 5.71e-04 | 92 | 9 | 2 | CID000030243 | |
| Drug | AC1MMLID | 5.71e-04 | 92 | 9 | 2 | CID000013245 | |
| Drug | ruthenium | 5.96e-04 | 94 | 9 | 2 | CID000023950 | |
| Drug | telmisartan | 6.21e-04 | 96 | 9 | 2 | CID000065999 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.93e-07 | 3 | 8 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.93e-07 | 3 | 8 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.01e-04 | 80 | 8 | 2 | DOID:6432 (biomarker_via_orthology) | |
| Disease | beverage consumption measurement | 2.16e-04 | 83 | 8 | 2 | EFO_0010088 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.19e-03 | 195 | 8 | 2 | DOID:1574 (implicated_via_orthology) | |
| Disease | basophil percentage of leukocytes | 1.83e-03 | 243 | 8 | 2 | EFO_0007992 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WLYGSFQGNFGWFPC | 796 | Q9NZM3 | |
| FGWWAGSEEPFSFYG | 26 | Q5TGI0 | |
| FGWIGCRWYGWAGFF | 101 | Q6U736 | |
| CRWYGWAGFFFGCGS | 106 | Q6U736 | |
| AWYSWPNVVLCFFGG | 86 | Q9H3U5 | |
| ISFYGGFPFWGGLWF | 101 | Q9BY19 | |
| YPSGNCGLYYSSGWW | 366 | Q14314 | |
| CWKYYCLPTGWANFG | 2651 | P21817 | |
| RCWKYYCLPGGWGNF | 2616 | Q92736 | |
| WGCIVFSGSYAWANF | 21 | Q6RW13 |